Posted 10th July 2019 by Jane Williams
The PhotoSeed Technology
Enhancing photosynthesis is a critical step to increasing crop yields. This complex 156 step biochemical process has been the subject of many studies in multiple crops. While some step wise gains have been made, the true potential for increasing photosynthesis has not been realized potentially due to the negative feedback mechanisms that exist within plants to regulate this process.
Posted 3rd July 2019 by Jane Williams
2019 may prove to be propitious in terms of meaningful improvements to the regulatory strictures facing agricultural biotech and biologically based products.
In a move that will hopefully lead to positive changes in the regulatory situation facing ag biotech products, on June 11, 2019, President Trump signed an Executive Order directing the heads of the U.S. Department of Agriculture (USDA), Environmental Protection Agency (EPA), and Food and Drug Administration (FDA) to take specific steps to streamline and improve the regulatory processes applicable to the products of agricultural biotechnology.
Posted 28th June 2019 by Jane Williams
The ECJ ruling on GMOs has raised pertinent issues. How will it impact on current and future research? What are the optimum routes to progressing plant research?
In light of the ruling, it was a good time to welcome experts in policy and regulatory affairs to the recent 7th Plant Genomics & Gene Editing Congress: Europe to explore these issues. We’re lucky to be able to share this presentation from the event for those that weren’t able to make it. Watch it here.
Posted 21st June 2019 by Joshua Sewell
Anyone involved in the field of agriculture and biotechnology would have been unable to ignore the ECJ ruling on case C-528/16 in July 2018. The ruling confirmed that all plants obtained by any form of mutagenesis are GMOs as defined by Directive (EC) no. 2001/18 and rejected an annulment of mutagenesis exemption (Annex IB of Directive 2001/18. With significant ramifications across the industry, the ECJ stance on gene edited crops and GMOs was a major focus of the 7th Plant Genomics & Gene Editing Congress: Europe.
Posted 14th June 2019 by Joshua Sewell
Researchers at the Polytechnic University of Madrid (UPM) in Spain, in collaboration with scientists with PlantResponse Biotech, S.L., are conducting research on a novel fungal endophyte that confers crop fitness benefits, particularly in alkaline soils.
Posted 12th April 2019 by Joshua Sewell
A key feature of our Congresses is the opportunity given to early career researchers to present their work.
At the upcoming 7th Plant Genomics & Gene Editing Congress: Europe, Egem Ozbudak will be one of four early career researchers to be given a 15-minute platform to present their work and receive a free registration pass for both days of the conference.
He will be discussing his research project on Colletotrichum acutatum, the causative agent of anthracnose crown and fruit rot, recognized as the second most important pathogen of strawberries on the globe due to its economic impacts.
Posted 29th March 2019 by Joshua Sewell
Günter Welz is part of the Open Innovation and Strategic Partnerships department at Bayer. He scouts for and builds relationships with external innovators in academia and business to enrich Bayer’s R&D pipeline, using various tools like the Open Innovation website and the venture capital arm.
Posted 18th March 2019 by Joshua Sewell
Regulation of emerging technology such as genome editing has mainly focused on responding to the consequences of innovation. The classical regulatory model of “identification-quantification-assessment-safety management” takes a risk-oriented approach to regulation of emerging technology and focuses on constraining the practice of science based on ethics, and administrative and risk management procedures.